If you paid for a Lipitor prescription in the past few years, you might have overpaid. Pfizer has been accused of reaping huge profits by illegally conspiring to keep generic versions of Lipitor off the market. The end result: Americans paying for Lipitor may have paid over-inflated prices for their prescription.
Zimmerman Reed represents Lipitor purchasers who filed lawsuits in federal court in New Jersey against Pfizer, the manufacturer of Lipitor, alleging that they illegally agreed with a generic drug manufacturer to keep more affordable generic versions away from the public. The generic drug company agreed not to sell any generic Lipitor in the United States and Pfizer agreed that the generic could be sold in other countries. If you bought Lipitor in the past few years, you may have overpaid.
How We Can Help
Fortunately, antitrust laws allow customers to stand up and take action. If you paid for Lipitor after March 25, 2010, we are available to assist you in determining if you may have paid more than you should have. If you would like to talk with a lawyer about your potential claim, please call 1.800.887.8029 or submit a free case review form. Zimmerman Reed is experienced in handling antitrust cases and we welcome any questions you may have.